Login / Signup

Insomnia symptoms and neurofunctional correlates among adults receiving buprenorphine for opioid use disorder.

Augustus M WhiteMichelle EglovitchAnna Beth Parlier-AhmadJoseph M DzierzewskiMorgan H JamesJames M BjorkF Gerard MoellerCaitlin Eileen Martin
Published in: PloS one (2024)
Insomnia was prevalent among adults receiving buprenorphine for OUD. Insomnia was associated with neurofunctional performance, which may impact OUD treatment trajectories. Our findings indicate potential targets in the development of personalized treatment plans for patients with co-morbid insomnia and OUD. To inform the development of novel treatment strategies, more research is needed to understand the potential mechanistic links between sleep disturbances and substance use.
Keyphrases
  • sleep quality
  • depressive symptoms
  • weight loss
  • obese patients